CLLSLL

People with chronic lymphocytic leukemia or small lymphocytic lymphoma (CLL/SLL) often rely on covalent Bruton's Tyrosine Kinase inhibitors (cBTKis) to manage their condition. These drugs are crucial, but they come with a catch: they can sometimes lead to heart problems. Doctors have been digging i

Venetoclax is a common treatment for chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL). While it's effective, it needs close supervision to ensure safety. But how important is this constant monitoring, especially for patients at low or medium risk of tumor lysis syndrome (TLS)?